Our research and development center in Berlin serves as the epicenter for pioneering innovations in in-vitro diagnostics. Our primary focus is on developing a ‘platform’ for the molecular detection of pathogens and a ‘dispensing system’ to produce a tube for the collection of human samples.
Our goal at ICHORtec is to create a pioneering ‘in-vitro’ diagnostic system that enables point-of-care in-vitro diagnostics with 100% specificity. This innovative platform is characterized by speed, sensitivity, precision, and cost-efficiency, far surpassing current gold standards in medical diagnostics.
Our patented technology, known as ‘Fluorimetry of Molecular Binding’ (FMB®), is based on the fundamental principles of quantum physics. It allows for the direct detection of various molecules, including mRNA, dsDNA, ssRNA and ions.
Our in-vitro diagnostics ‘platform’ utilizes advanced optical analysis algorithms to identify pathogens, playing a crucial role in the early detection and treatment of infectious diseases. The dispensing system focuses on research, development, and industrial production of test systems made available as tubes. The sample collection tube contains polymers that react specifically to pathogens.
At our Berlin location, we work passionately to advance this technology and explore its diverse applications, aiming to enhance global medical diagnostics and healthcare.